OB-Tools

Noninvasive Uterine and Fetal Monitoring

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in January 2003, OB-Tools operates with 11–50 employees. The company achieved a significant milestone in September 2015 when its fetal heart rate monitoring unit received FDA approval, paving the way for marketing its non-invasive labor monitoring device.

Business overview

OB-Tools develops technology for noninvasive uterine and fetal monitoring, focusing on improving maternal and fetal health outcomes. Its core product, the TrueLabor System with LaborTrack Technology, is designed to identify, measure, and evaluate uterine contractions and fetal heart rates throughout pregnancy and labor. This system helps maternal fetal medicine specialists and obstetricians distinguish between true and false labor signs, providing accurate readings even in challenging conditions. The company serves the healthcare industry, specifically targeting hospitals and medical professionals in the gynecology and women's health sectors, and operates within the Digital Health and Medical Technologies sector.

Strategic signal

In September 2015, OB-Tools announced it would begin marketing its non-invasive labor monitoring device following FDA approval. This event signals a critical transition from development to commercialization, validating the technology's safety and efficacy for clinical use and opening significant market opportunities in maternal-fetal healthcare.

Log in to access full profile

Company Intelligence Q&A

What is the primary product developed by OB-Tools?
OB-Tools has developed the TrueLabor System with LaborTrack Technology, a noninvasive device designed for monitoring uterine contractions and fetal heart rates throughout pregnancy and labor.
When did OB-Tools receive FDA approval for its fetal heart rate monitoring unit?
OB-Tools' fetal heart rate monitoring unit received FDA approval in 2015.
What is the main purpose of the TrueLabor System?
The TrueLabor System helps doctors and nurses distinguish between true and false labor signs by providing accurate, noninvasive readings of uterine contractions and fetal heart rates.
In what sector does OB-Tools primarily operate?
OB-Tools operates primarily in the Health Tech & Life Sciences sector, focusing on medical devices and digital healthcare for women's health.
Log in to access full profile